Cargando…
The role of epigenetic modifications in drug resistance and treatment of breast cancer
BACKGROUND: Breast cancer is defined as a biological and molecular heterogeneous disorder that originates from breast cells. Genetic predisposition is the most important factor giving rise to this malignancy. The most notable mutations in breast cancer occur in the BRCA1 and BRCA2 genes. Owing to di...
Autores principales: | Karami Fath, Mohsen, Azargoonjahromi, Ali, Kiani, Arash, Jalalifar, Fateme, Osati, Parisa, Akbari Oryani, Mahsa, Shakeri, Fateh, Nasirzadeh, Farhad, Khalesi, Behman, Nabi-Afjadi, Mohsen, Zalpoor, Hamidreza, Mard-Soltani, Maysam, Payandeh, Zahra |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9238060/ https://www.ncbi.nlm.nih.gov/pubmed/35764927 http://dx.doi.org/10.1186/s11658-022-00344-6 |
Ejemplares similares
-
Exosome application in treatment and diagnosis of B-cell disorders: leukemias, multiple sclerosis, and arthritis rheumatoid
por: Karami Fath, Mohsen, et al.
Publicado: (2022) -
Anti-cancer peptide-based therapeutic strategies in solid tumors
por: Karami Fath, Mohsen, et al.
Publicado: (2022) -
Current understanding of epigenetics role in melanoma treatment and resistance
por: Karami Fath, Mohsen, et al.
Publicado: (2022) -
Ephrin (Eph) receptor and downstream signaling pathways: a promising potential targeted therapy for COVID‑19 and associated cancers and diseases
por: Zalpoor, Hamidreza, et al.
Publicado: (2022) -
Recent Advances in Glioma Cancer Treatment: Conventional and Epigenetic Realms
por: Karami Fath, Mohsen, et al.
Publicado: (2022)